Scarica l'app Stockscreener
19.42
0.54%
-0.105
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
MSN Money - MSN
FDA flags high-risk recall for Tandem Diabetes Mobi pumps - MSN
TD Cowen Raises Tandem Diabetes (TNDM) Price Target, Keeps Buy Rating - Insider Monkey
Vanguard Capital Management files 13G for Tandem Diabetes Care (NYSE: TNDM) — 3.55M shares - Stock Titan
10 Best Medical Stocks to Buy Under $30 - Insider Monkey
Tandem Diabetes Care Announces Upcoming Conference Presentations - Yahoo Finance
Vanguard Portfolio Management (TNDM) reports 4.05M shares, 5.91% stake - Stock Titan
Tandem Diabetes Care Opens with 5.69% Gain, Outpacing S&P 500's 2.51% Increase - Markets Mojo
TNDM Stock Chart | TANDEM DIABETES CARE INC (NASDAQ:TNDM) - ChartMill
Strength seen in Tandem Diabetes Care (TNDM): Can its 9.1% jump turn into more strength? - MSN
TNDM Stock Price, Quote & Chart | TANDEM DIABETES CARE INC (NASDAQ:TNDM) - ChartMill
Tandem Diabetes Care’s Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes - BioSpace
Tandem Diabetes Care (TNDM) Corporate presentation Summary - Quartr
FDA clears Control-IQ+AID technology for use in pregnancy complicated by type 1 diabetes - Contemporary OB/GYN
Tandem rises as Piper Sandler upgrades on pharmacy strategy - MSN
TNDM: Tandem Diabetes Receives FDA Approval for Control-IQ+ in P - GuruFocus
Tandem Diabetes’ Control-IQ+ Wins FDA Nod for T1D in Pregnancy - Medical Product Outsourcing
Tandem gains as Truist becomes latest to upgrade on new pharmacy model - MSN
Tandem Diabetes Care, Inc. (TNDM) reports Q4 loss, tops revenue estimates - MSN
Tandem Diabetes upgraded at Citi on risk-reward setup - MSN
Stocks generating improved relative strength: Tandem Diabetes Care - MSN
Tandem Diabetes Care (TNDM) TD Cowen 46th Annual Health Care Conference Summary - Quartr
Rothschild & Co Redburn Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $45 - Moomoo
FDA flags most serious recall for Tandem Mobi insulin pumps - MSN
FDA Flags High-Risk Recall For Tandem Diabetes Mobi Pumps - Benzinga
(TNDM) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
B of A Securities upgrades Tandem Diabetes Care (TNDM) - MSN
Tandem Diabetes Care (TNDM) reports Q4 earnings: What key metrics have to say - MSN
Tandem Diabetes Care Inc (TNDM) Stock Up 3.7% and Still Underval - GuruFocus
Tandem recalls Mobi insulin pumps over software malfunction - MedTech Dive
A Look at Tandem Diabetes Care Inc (TNDM) After 3.0% Gain -- GF Value $33.02 vs Price $21.24 - GuruFocus
TNDM Maintained by TD Cowen -- Price Target Raised to $28.00 - GuruFocus
TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $28 - Moomoo
Tandem Diabetes stock price target raised to $28 by TD Cowen - Investing.com Canada
TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $28 - Moomoo
Tandem (TNDM) Stock: Downside Risk Overview (Slight Rise) 2026-04-18ATR Levels - Cổng thông tin điện tử Tỉnh Sơn La
Tandem Diabetes (TNDM) COO exercises RSUs; shares withheld for taxes - Stock Titan
Tandem Diabetes Care Inc (TNDM) Shares Surge 4.8% -- What GF Score of 74 Tells Investors - GuruFocus
Mizuho Securities Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $22 - Moomoo
Ideas Watch: Can Tandem Diabetes Care Inc continue delivering strong returnsPortfolio Performance Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
0.57%
1.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):